請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33488
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 鄧麗珍(Lee-Jene Teng) | |
dc.contributor.author | Yu-Hsuan Huang | en |
dc.contributor.author | 黃聿玄 | zh_TW |
dc.date.accessioned | 2021-06-13T04:43:20Z | - |
dc.date.available | 2007-08-02 | |
dc.date.copyright | 2006-08-02 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-18 | |
dc.identifier.citation | Aires de Sousa M, Crisostomo MI, Sanches IS, Wu JS, Fuzhong J, Tomasz A,
de Lencastre H. Frequent recovery of a single clonal type of multidrug-resistant Staphylococcus aureus from patients in two hospitals in Taiwan and China. J Clin Microbiol 2003;41:159-63. Archer GL. Staphylococcus aureus:a well-armed pathogen. Clin Infect Dis 1998;26:1179-81. Archer GL, Niemeyer DM. Origin and evolution of DNA associated with resistance to methicillin in staphylococci. Trends Microbiol 1994;2:343-7. Arciola CR, Campoccia D, Gamberini S, Donati ME, Baldassarri L, Montanaro L. Occurrence of ica genes for slime synthesis in a collection of Staphylococcus epidermidis strains from orthopedic prosthesis infections. Acta Orthop Scand 2003;74:617-621. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359:1819-27. Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, Sparks R, Donlan RM, Martinez P, Mongkolrattanothai K, Butler JC. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine Leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189:1565-73. Berger-Bachi B. Genetic basis of methicillin resistance in Staphylococcus aureus. Cell Mol Life Sci 1999;56:764-70. Berger-Bachi B, Rohrer S. Factors influencing methicillin resistance in Staphylococci. Arch Microbiol 2002;178:165-71. Blum RA, Rodvold KA. Recognition and importance of Staphylococcus epidermidis infections. Clin.Pharm 1987;6:464-75. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989;320:1188-96. Buescher ES. Community-acquired methicillin-resistant Staphylococcus aureus in pediatrics Curr Opin Pediatr 2006;17:67-70. Carleton HA, Diep BA, Charlebois ED, Sensabaugh GF, Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004;190:1730-8. Chambers HF. Methicillin resistance in Staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997;10:781-91. Chen CJ, Huang YC. Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan. J Microbiol Immunol Infect 2005;38:376-82. Chen CJ, Huang YC, Chiu CH, Su LH, Lin TY. Clinical features and genotyping analysis of community-acquired methicillin-resistant Staphylococcus aureus infections in Taiwanese children. Pediatr Infect Dis J 2005;24:40-5. Chen ML, Chang SC, Pan HJ, Hsueh PR, Yang LS, Ho SW, Luh KT. Longitudinal analysis of methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J Formos Med Assoc 1999;98:426-32. Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, Jamklang M, Chavalit T, Song JH, Hiramatsu K. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother 2006;50:1001-12. Chu CY, Wang SM, Lin HC, Liu CC. A clinical and microbiological comparison of Staphylococcus aureus toxic shock and scalded skin syndromes in children. Clin Infect Dis 2006;42:181-5. de A Trindade P, Pacheco RL, Costa SF, Rossi F, Barone AA, Mamizuka EM, Levin AS. Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005;43:3435-7. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 2005;40:562-73. Diederen BM, Kluytmans JA. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 2006;52:157-68. Diekema DJ, BootsMiller BJ, Vaughn TE, Woolson RF, Yankey JW, Ernst EJ, Flach SD, Ward MM, Franciscus CL, Pfaller MA, Doebbeling BN. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004;38:78-85. Diep BA, Carleton HA, Chang RF, Sensabaugh GF, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006;193:1495-503. Donnio PY, Preney L, Gautier-Lerestif AL, Avril JL, Lafforgue N. Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin- resistant Staphylococcus aureus isolates from a French hospital over an 11 year period. J Antimicrob Chemother 2004;53:808-13. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Etienne J, Richet H. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine Leukocidin. Clin Infect Dis 2002;35:819-24. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000;38:1008-15. Felten A, Grandry B, Lagrange PH, Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): a disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 2002;40:2766-71. Fey PD, Said-Salim B, Rupp ME, Hinrichs SH, Boxrud DJ, Davis CC, Kreiswirth BN, Schlievert PM. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003;47:3926-34. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001;39:3727-32. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44. Fuda C, Suvorov M, Vakulenko SB, Mobashery S. The basis for resistance to β-lactam antibiotics by penicillin binding protein 2a of methicillin-resistant Staphylococcus aureus. J Bacteriol 2004;279:40802-6. Garcya-Castellanos R, Mallorquy-Fernandez G, Marrero A, Potempa J, Coll M, Gomis-Ruth FX. On the transcriptional regulation of methicillin resistance. J Biol Chem 2004;279:17888-96. Garcya-Castellanos R, Marrero A, Mallorquy-Fernandez G, Potempa J, Coll M, Gomis-Ruth FX. Three-dimensional structure of mecI. J Biol Chem 2003;278:39897-905. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D, Etienne J. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine Leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients. Lancet 2002;359:753-9. Gould IM. The clinical significance of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2006;61:277-82. Gregory PD, Lewis RA, Curnock SP, Dyke KG. Studies of the repressor (BlaI) of beta-lactamase synthesis in Staphylococcus aureus. Mol Microbiol 1997;24:1025-37. Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D, Moore KA, Cheek JE. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-5. Gross-Schulman S, Dassey D, Mascola L, Anaya C. Community-acquired methicillin-resistant Staphylococcus aureus. JAMA 1998;280:421-2. Hanssen AM, Ericson Sollid JU. SCCmec in staphylococci: genes on the move. FEMS Immunol Med Microbiol 2006;46:8-20. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-8. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001;9:486–93. Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau YR. Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 1999;32:239-49. Hsu LY, Koh YL, Chlebicka NL, Tan TY, Prabha K, Raymond T-PL, Tee N, Barkham T, Koh TH. Establishment of ST30 as the predominant clonal type among community-associated methicillin-resistant Staphylococcus aureus isolates in Singapore.J Clin Microbiol 2006;44:1090-3. Hsueh PR, Teng LJ, Chen WH, Pan HJ, Chen ML, Chang SC, Luh KT, Lin FY. Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001. Antimicrob Agents Chemother 2004;48:1361-4. Huygens F, Stephens AJ, Nimmo GR, Giffard PM. MecA locus diversity in methicillin-resistant Staphylococcus aureus isolates in Brisbane, Australia, and the development of a novel diagnostic procedure for the western samoan phage pattern clone. J Clin Microbiol 2004;42:1947-55. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hriamatsu K. Structural comparison of three types of Staphylococcal Cassette Chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2001;45:1323-36. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V Staphylococcal Cassette Chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004;48:2637-51. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F, Nesme X, Etienne J, Vandenesch F. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 2002;70:631-41. Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. An outbreak of community-acquired foodborne illness caused by methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2002;2:82-4. Katayama Y, Zhang HZ, Chambers HF. PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrob Agents Chemother 2004;48:453-9. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus:current perspectives. Clin Microbiol Infect 2006;12:9-15. Kristiansen MM, Leandro C, Ordway D, Martins M, Viveiros M, Pacheco T, Kristiansen JE, Amaral L. Phenothiazines alter resistane of methicillin-resistant strains of Staphylococcus aureus(MRSA) to oxacillin in vitro. Int J Antimicrob Agents 2003;22:250-3. Laurent F, Lelievre H, Cornu M, Vandenesch F, Carret G, Etienne J, Flandrois JP. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 2001;47:277-83. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999;29:797-800. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998;339:520-32. Lu PL, Chin LC, Peng CF, Chiang YH, Chen TP, Ma L, Siu LK. Risk factors and molecular analysis of community methicillin-resistant Staphylococcus aureus carriage. J Clin Microbiol 2005;43:132-9. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, Daum RS, Hiramatsu K. Novel type of Staphylococcal Cassette Chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002;46:1147-52. Maltezou HC, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Angents 2006;27:87-96. McKinney TK, Sharma VK, Craig WA, Archer GL. Transcription of the gene mediating methicillin resistance in Staphylococcus aureus (mecA) is corepressed but not coinduced by cognate mecA and beta-lactamase regulators. J Bacteriol 2001;183:6862-8. Miller LG, Perdreau-Remington F, Rieg G, Mehdi S, Perlroth J, Bayer AS, Tang AW, Phung TO, Spellberg B. Necrotizing fasciitis caused by community-associated methicillin- resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-53. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Besser JM, O'Boyle C, Danila RN, Cheek JE, Osterholm MT, Moore KA, Smith KE. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin Infect Dis 2001;33:990-6. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O'Boyle C, Danila RN, Lynfield R. Comparsion of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-84. O'Brien FG, Pearman JW, Gracey M, Riley TV, Grubb WB. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol 1999;37:3858-62. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002;40:4289-94. Rings T, Findlay R, Lang S. Ethnicity and methicillin-resistant Staphylococcus aureus in South Auckland. N Z Med J 1998;111:151. Robinson DA, Enright MC. Comparative molecular analysis of community- or hospital- acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:196-203. Rosato AE, Craig WA, Archer GL. Quantitation of mecA transcription in oxacillin-resistant Staphylococcus aureus clinical isolates. J Bacteriol 2003;185:3446-52. Rosato AE, Kreiswirth BN, Craig WA, Eisner W, Climo MW, Archer GL. MecA-blaZ corepressors in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 2003;47:1460-3. Saiman L, O'Keefe M, Graham PL 3rd, Wu F, Said-Salim B, Kreiswirth B, LaSala A, Schlievert PM, Della-Latta P. Hospital transmission of community-acquired methicillin- resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003;37:1313-9. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, Ray SM, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647-56. Sharma VK, Hackbarth CJ, Dickinson TM, Archer GL. Interaction of native and mutant mecI repressors with sequences that regulate mecA, the gene encoding penicillin binding protein 2a in methicillin-resistant Staphylococci. J Bacteriol 1998;180: 2160-6. Shukla SK, Ramaswamy SV, Conradt J, Stemper ME, Reich R, Reed KD, Graviss EA. Novel polymorphisms in mec genes and a new mec complex type in methicillin-resistant Staphylococcus aureus isolates obtained in rural Wisconsin. Antimicrob Agents Chemother 2004;48:3080-5. Stacey AR, Endersby KE, Chan PC, Marples PP. An outbreak of methicillin-resistant Staphylococcus aureus infection in a rugby football teams. Br J Sports Med 1998;32:153-4. Strandén A, Frei R, Widmer AF. Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis? J Clin Microbiol 2003;41:3181-6. Takizawa Y, Taneike I, Nakagawa S, Oishi T, Nitahara Y, Iwakura N, Ozaki K, Takano M, Nakayama T, Yamamoto T. A Panton-Valentine leucocidin (PVL)-positive community- acquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multiple-drug resistance plasmid, and other more-typical PVL-negative MRSA strains found in Japan. J Clin Microbiol 2005;43:3356-63. Trindada P, Pacheco RL, Costa SF, Rossi F, Barone AA, Mamizuka EM, Levin AS. Prevalence of SCCmec type IV in nosocomial bloodstream isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005;43:3435-7. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide emergence. Emerg Infect Dis 2003;9:978-84. Wang CC, Lo WT, Chu ML, Siu LK. Epidemiological typing of community-acquired methicillin-resistant Staphylococcus aureus isolates from children in Taiwan. Clin Infect Dis 2004;39:481-7. Wang JT, Chen YC, Yang TL, Chang SC. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis 2002;42:199-203. Wannet WJ, Spalburg E, Heck ME, Pluister GN, Willems RJ, De Neeling AJ. Widespread dissemination in The Netherlands of the epidemic berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin. J Clin Microbiol 2004; 42:3077-82. Wisplinghoff H, Ewertz B, Wisplinghoff S, Stefanik D, Plum G, Perdreau-Remington F, Seifert H. Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998. J Clin Microbiol 2005;43:5445 -51. Wisplinghoff H, Rosato AE, Enright MC, Noto M, Craig W, Archer GL. Related clones containing SCCmec Type IV predominate among clinically significant Staphylococcus epidermidis isolates. Antimicrob Agents Chemother 2003;47:3574-9. Wu CY, Alborn WE Jr, Flokowitsch JE, Hoskins J, Unal S, Blaszczak LC, Preston DA, Skatrud PL. Site-directed mutagenesis of the mecA gene from a methicillin-resistant strain of Staphylococcus aureus. J Bacteriol 1994;176:443-9. Zetola N, Francis JS, Nuermberger EL, Bishai WR. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275-86. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/33488 | - |
dc.description.abstract | Methicillin-resistant Staphylococcus aureus (MRSA) 是造成院內感染的重要致病菌, 一般而言帶有危險因子(如:長期住院、移植人工瓣膜、手術等…)的病人較容易受到感染, 這類的感染通稱為Hospital-acquired MRSA (HA-MRSA) infection, 但近幾年發現在健康的人也有受到MRSA感染的情形發生, 稱之為Community- acquired MRSA (CA-MRSA) 感染。 而在先前的研究中發現HA-MRSA主要以第三型SCCmec為主, 而CA-MRSA大都為第四或第五型SCCmec, 因此本次實驗隨機收集了382株HA-MRSA (1999年到2005年) 和26株CA-MRSA (2005年), 進行SCCmec的分析, 發現HA-MRSA仍以第三型的為主, 而CA-MRSA則是第四或第五型。 但值得注意的是第四型SCCmec在HA-MRSA的分布有增多的趨勢, 因此將菌株分為HA-MRSA (SCCmec III)、HA-MRSA (SCCmec IV or V)、CA-MRSA三大群討論, 分別針對病人基本資料、毒力因子、抗藥型態、基因背景等進行分析, 結果發現菌株含三個主要的clone (A, B, C), 分別屬於SCCmec III, IV, V, 彼此間的差異甚大, 特別的是clone B和C同時傳播於醫院和社區間。 另外針對SCCmec第四型在醫院分布增多的現象做了進一步的討論, 發現快速的生長和更強的形成biofilm的能力可能提供了生長的優勢, 使之適合在醫院內傳播。
此外, 根據先前的研究推測MRSA SCCmec IV的cassette來源可能和coagulase- negative的Staphylococcus spp.有關, 因此選取了具SCCmec第四型的31株MRSA和36株MRSE, 分別針對基因背景和cassette的結構進行分析彼此間是否具關聯性。 結果發現MRSA和MRSE cassette的結構並不相同, 因此推斷MRSA第四型的cassette由MRSE直接傳遞過來的可能性甚小。 此外第四型的cassette缺少了mecI (repressor), 理論上對於oxacillin的MICs應該極高, 但上述的67株菌種對於oxacillin的MICs分布變異極大, 因此分別從mecA基因序列、promoter region序列、另一個調控的repressor (blaI)的序列和MICs間的關聯性來做探討, 但結果發現彼此間並無關聯性, 因此更進一步的藉Northern Blot的實驗看RNA的表現量和MICs之間的關係, 而結果發現無論MICs的高或低, mecA和blaI的表現量並無明顯差異。又在先前的研究中指出對oxacillin的抗性可能受efflux pump的調控, 因此更近一步的探討當抑制efflux pump的功能時, 對oxacillin的MICs值是否會改變, 而實驗的結果發現MRSE對oxacillin抗性的變異受efflux pump的影響極大, 而MRSA則不受影響, 因此推測造成MRSA抗性的變異可能有其他的因子存在。 | zh_TW |
dc.description.abstract | The SCCmec types of 382 hospital-acquired methicillin resistant Staphylococcus aureus (HA-MRSA) isolates collected from 1999 to 2005, and 26 community-acquired MRSA (CA-MRSA) isolates recovered in 2005 from northern Taiwan were analyzed retrospectively. Although the majority of HA-MRSA continued to possess SCCmec III in each year throughout the study period, the prevalence of SCCmec type IV in HA-MRSA showed a rapid increase in 2005, reaching 45% after maintaining a fairly steady rate from 3% to 20% from 1999 through 2004. Analysis of randomly selected isolates each year (30 SCCmec type III HA-MRSA, 39 HA-MRSA with SCCmec IV or V and 26 CA-MRSA) by PFGE revealed three major pulsotypes (A, B, and C). Pulsotypes B and C containing SCCmec type IV and V, respectively, were detected not only in CA but also in HA isolates. In the aspect of toxin genes detection, six toxin genes had significantly different distribution in HA-MRSA with SCCmec III and CA-MRSA while there is only one difference between CA- and HA-MRSA carrying SCCmec IV and no difference between CA-and HA-MRSA with SCCmec V. Furthermore, analysis of representative members of the three major pulsotypes by multilocus sequence typing (MLST) revealed that two STs, ST239 and ST59. All SCCmec IV and V MRSA shared the same ST59 genetic background. The more rapid growth rates and better biofilm forming ability may contribute to the spread of SCCmec type IV:ST59 between community and hospital. Therefore, SCCmec type IV, which is usually community-acquired, may become nosocomial in the study.
Besides, in previous study indicated that SCCmec IV cassette of MRSA may be transferred from other coagulase-negative Staphylococcus spp. PFGE, MLST, and mecA down stream were analyzed to realize the relationship of SCCmec cassette between MRSA and MRSE carrying SCCmec IV. The result showed difference in structure between the two species, therefore, the possibility was limited of SCCmec cassette transferred from MRSE to MRSA directly. In addition, variation of resistance to oxacillin was observed in SCCmec IV MRSA and MRSE. The correlation between sequence mutations, RNA level of mecA regulation system, efflux pump and oxacillin MICs was concerned. Only the resistance to oxacillin in MRSE changes while inhibiting the function of efflux pump. As a result, efflux pump played an important role regulating the resistance to oxacillin in MRSE while there would be other factors regulating in MRSA. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T04:43:20Z (GMT). No. of bitstreams: 1 ntu-95-R93424002-1.pdf: 676519 bytes, checksum: 974460968737224d2a285e6a52284316 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 英文摘要………………………………………………………………1
中文摘要………………………………………………………………2 緒論……………………………………………………………………3 實驗設計與目的………………………………………………………6 材料與方法……………………………………………………………7 結果……………………………………………………………………34 討論……………………………………………………………………42 實驗之附圖表…………………………………………………………47 參考文獻………………………………………………………………61 | |
dc.language.iso | zh-TW | |
dc.title | 抗methicillin葡萄球菌之分子流行病學和抗藥基因分析 | zh_TW |
dc.title | Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis and Characterization of Resistance Genes | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 賴信志(Hsin-Chih Lai),薛博仁(Po-Ren Hsueh) | |
dc.subject.keyword | 金黃色葡萄球菌,分子流行病學,抗藥基因, | zh_TW |
dc.subject.keyword | methicillin-resistant Staphylococcus aureus,SCCmec, | en |
dc.relation.page | 69 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-18 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 醫學檢驗暨生物技術學研究所 | zh_TW |
顯示於系所單位: | 醫學檢驗暨生物技術學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 660.66 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。